EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY-NC 4.0

Body Mass Index and Risk of Female Reproductive System Tumors Subtypes: A Meta-Analysis Using Mendelian Randomization

Xi-Ya Jiang, Lan Zheng, Min Xiong, Sen-Lin Wang, Qin-Qin Jin, Yin-Ting Yang, Ya-Xing Fang, Lin Hong, Jie Mei, Shu-Guang Zhou iD

Technology in Cancer Research & Treatment · 2024

DOI: 10.1177/15330338241277699 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Technology in Cancer Research & Treatment, 2024. Verfasst von Xi-Ya Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Maternity and Child Healthcare Hospital Affiliated to Anhui Medical University, Anhui Province Maternity and…. Hauptthemen laut MEDLINE: Body Mass Index, Genetic Predisposition to Disease, Genital Neoplasms, Female. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Higher Education Institutions of Anhui Province, Research Fund Project of Anhui Medical University, Applied Medicine Research Project of Hefei Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

A strong association was previously established between body mass index (BMI) and female reproductive system tumors; however, the causal relationship is unclear. We conducted a Mendelian randomization (MR) study to further explore this association.

Methods

Genetic information for BMI was retrieved from a published genome-wide association study involving 339,224 participants. Genetic associations with five common female reproductive system tumors were obtained from the FinnGen, UK Biobank studies, and other large consortia.

Results

Genetic predisposition towards BMI exhibits a significant association with multiple tumors of the female reproductive system. Specifically, for every 1-unit increase in BMI log-transformed odds ratio (OR). The OR fluctuations overall for patients with breast cancer ranged from 0.661 to 0.996 (95% confidence interval [CI],0.544-1.000, P < 0.05). When stratified by estrogen receptor (ER) status, the OR for patients with ER (+) breast cancer ranged from 0.782 to 0.844 (95% CI, 0.616-0.994, P < 0.05) and that for those with ER (-) breast cancer ranged from 0.663 to 0.789 (95% CI, 0.498-0.991, P < 0.05). Additionally, ORs were as follows for cancer types: 1.577–1.908 (95% CI, 1.049-2.371, P < 0.05) for endometrial carcinoma; 1.216–1.303 (95% CI, 1.021-1.591, P < 0.05) for high-grade serous ovarian cancer; 1.217 (95% CI, 1.034-1.432, P < 0.05) for low-grade malignant serous ovarian cancer; and 1.502 (95% CI, 1.112-2.029, P < 0.05) for endometrioid ovarian carcinoma. Furthermore, our findings indicated that genetic predisposition towards BMI did not exhibit a causal association with uterine fibroids, cervical precancerous lesions, or cervical cancer itself.

Conclusion

A genetic association was established between a high BMI and high risk of developing multiple tumors of the female reproductive system and their associated subtypes. This underscores the significance of taking measures to prevent reproductive system tumors in women who have a high BMI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Body Mass IndexGenetic Predisposition to DiseaseGenital Neoplasms, FemaleFemaleHumansGenome-Wide Association StudyMendelian Randomization AnalysisOdds RatioPolymorphism, Single NucleotideReceptors, EstrogenRisk Factors

Stichwörter der Autor:innen

Mendelian randomizationbody mass indexfemale reproductive system tumormeta-analysisobesity

Substanzen

Receptors, Estrogen

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, Maternity and Child Healthcare Hospital Affiliated to Anhui Medical University, Anhui Province Maternity and Child Healthcare Hospital, Hefei, Anhui 230001, China.
  • Department of Gynecology and Obstetrics, The Fifth Clinical College of Anhui Medical University, Hefei, Anhui 230032, China.
  • Department of Gynecology and Obstetrics, Luan Maternity and Child Healthcare Hospital, Luan, Anhui 237001, China.
  • Department of Clinical Laboratory, Anhui Province Maternity and Child Healthcare Hospital, Hefei, Anhui 230001, China.

ORCID-Profile: Shu-Guang Zhou

Förderung

  • Natural Science Foundation of Higher Education Institutions of Anhui Province
  • Research Fund Project of Anhui Medical University
  • Applied Medicine Research Project of Hefei Health Commission
  • Postgraduate Innovation Research and Practice Program of Anhui Medical University

Zitieren

APA

Jiang, X. Y., Zheng, L., Xiong, M., Wang, S. L., Jin, Q. Q., Yang, Y. T., Fang, Y. X., Hong, L., Mei, J., & Zhou, S. G. (2024). Body Mass Index and Risk of Female Reproductive System Tumors Subtypes: A Meta-Analysis Using Mendelian Randomization. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338241277699

Vancouver

Jiang XY, Zheng L, Xiong M, Wang SL, Jin QQ, Yang YT, et al. Body Mass Index and Risk of Female Reproductive System Tumors Subtypes: A Meta-Analysis Using Mendelian Randomization. Technology in Cancer Research & Treatment. 2024. doi:10.1177/15330338241277699

BibTeX
@article{Jiang2024,
  author = {Jiang, Xi-Ya and Zheng, Lan and Xiong, Min and Wang, Sen-Lin and Jin, Qin-Qin and Yang, Yin-Ting and Fang, Ya-Xing and Hong, Lin and Mei, Jie and Zhou, Shu-Guang},
  title = {Body Mass Index and Risk of Female Reproductive System Tumors Subtypes: A Meta-Analysis Using Mendelian Randomization},
  journal = {Technology in Cancer Research & Treatment},
  year = {2024},
  doi = {10.1177/15330338241277699}
}
Kostenlos starten →